Clinical trial
Study On Bioavailability And Pharmacokinetics Of Various Doses Of Testosterone…
NCT00400335 · GlaxoSmithKline, Industry · Completed
Key facts
| NCT number | NCT00400335 |
|---|---|
| Title | Study On Bioavailability And Pharmacokinetics Of Various Doses Of Testosterone Administered With And Without Dutasteride |
| Official title | An Open Label Study to Evaluate the Impact of Novel Fixed-dose Testosterone/Dutasteride Combinations on the Relative Bioavailability of the Individual Dutasteride and Testosterone Components |
| Lead sponsor | GlaxoSmithKline, Industry |
| Status | Completed |
| Phase | Phase 1 |
| Study type | Interventional |
| Conditions | Hypogonadism, Male |
| Intervention type | Drug |
| Interventions | Nanomilled testosterone, commercially available dutasteride, Nanomilled dutasteride |
| Enrollment | 60 |
| Start date | Oct 1, 2006 |
| First posted | Nov 16, 2006 |
| Last update posted | Jun 4, 2012 |
| Countries | United States |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: